Loading…
Product type
Liraglutide is a synthetic analog of the human glucagon-like peptide-1 (GLP-1) hormone, primarily used in the treatment of type 2 diabetes and obesity. It works by stimulating insulin secretion in response to meals, reducing glucagon release, and slowing gastric emptying, which helps to lower blood sugar levels. Liraglutide is typically available in injectable form and is often prescribed for patients who have not achieved adequate glycemic control with diet and exercise alone.
| Chemical formula | C172H265N43O51 |
| Molecular weight | 3751.6 g/mol |
| Formulation | Lyophilized powder for injection |
| Storage conditions | Refrigerated at 2°C to 8°C |
| Shelf life | Typically 24 months from the date of manufacture |
When selecting Liraglutide as a pharmaceutical raw material, buyers should consider the required purity levels, which are typically above 95%. It's important to specify the desired formulation, such as whether it should be in lyophilized powder form or ready-to-use solution. Additionally, inquire about the supplier's certifications, such as Good Manufacturing Practices (GMP), and ensure that the product meets relevant pharmacopoeial standards. Quantities can vary based on production needs, so be clear about your requirements when requesting a quote.
Get quotes for Liraglutide
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
Liraglutide is primarily used to treat type 2 diabetes and assist with weight management.
Liraglutide is administered via subcutaneous injection.
Liraglutide should be stored refrigerated at 2°C to 8°C.
The typical shelf life is around 24 months from the date of manufacture.
Purity levels are typically above 95% for pharmaceutical grade Liraglutide.
Yes, suppliers should comply with Good Manufacturing Practices (GMP) and relevant pharmacopoeial standards.